BridgeBio Pharma Q3 Net Loss Narrows, Revenue Rises
MT newswire2026/10/29 20:55Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
04:55 PM EDT, 10/29/2026 (MT Newswires) -- BridgeBio Pharma (BBIO) reported a Q3 net loss late Thursday of $0.42 per diluted share, narrowing from a loss of $0.95 a year earlier. Analysts polled by FactSet expected a loss of $0.54. Revenue for the quarter ended Sept. 30 rose to $353.2 million, from $120.7 million a year earlier. Analysts expected $293.5 million.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
BUZZ-Drax wins contract for over 1 gigawatt data center project
路透社•2026/11/03 08:20
OPay backed by SoftBank suddenly halts US IPO, regulatory inquiries become the biggest uncertainty
Nigerian digital financial platform OPay announced the suspension of its IPO after revealing pricing, citing a regulatory inquiry. The company stated that the listing may be restarted in the coming months.
智通财经•2026/11/03 07:57
Crypto prices
More
Bitcoin
BTC
$76,849.16
-1.50%
Ethereum
ETH
$2,262.39
-1.09%
Tether USDt
USDT
$0.9983
-0.03%
BNB
BNB
$694.91
-1.87%
XRP
XRP
$1.25
+0.17%
USDC
USDC
$0.9996
-0.00%
Solana
SOL
$92.04
-2.51%
TRON
TRX
$0.3219
+1.95%
Hyperliquid
HYPE
$84
-2.72%
Zcash
ZEC
$1,137.72
-9.16%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now